You are here

  • Home
  • Archive
  • Volume 39, Issue 2
  • Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.

Article info

Article menu
Download PDFPDF
Research Article
Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.

Authors

    Citation

    Gyr K, Meier R, Häussler J, et al
    Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.
    Gut 1996;39:319-324.

    Publication history

    • First published August 1, 1996.
    Online issue publication 
    April 18, 2016

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.